MADALYN COSENSCI: Open Payments
NPI 1285369124 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 7 payments from 5 companies in 2025. Trend: 2023 $387 · 2024 $127 · 2025 $474
Food & beverage: $365Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $226 |
| Janssen Pharmaceuticals, Inc | 1 | $137 |
| ABBVIE INC. | 2 | $70 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, UZEDY, BOTOX, INGREZZA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
